Squarepoint’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.2K | Sell |
20,905
-991
| -5% | -$1.05K | ﹤0.01% | 2665 |
|
2025
Q1 | $23.9K | Sell |
21,896
-51,119
| -70% | -$55.7K | ﹤0.01% | 2672 |
|
2024
Q4 | $110K | Buy |
73,015
+29,722
| +69% | +$44.9K | ﹤0.01% | 2520 |
|
2024
Q3 | $64.5K | Sell |
43,293
-7,831
| -15% | -$11.7K | ﹤0.01% | 2407 |
|
2024
Q2 | $82.8K | Buy |
+51,124
| New | +$82.8K | ﹤0.01% | 2296 |
|
2023
Q3 | – | Sell |
-19,041
| Closed | -$119K | – | 2756 |
|
2023
Q2 | $119K | Sell |
19,041
-237,522
| -93% | -$1.49M | ﹤0.01% | 2178 |
|
2023
Q1 | $1.22M | Buy |
256,563
+238,395
| +1,312% | +$1.14M | 0.01% | 1065 |
|
2022
Q4 | $158K | Sell |
18,168
-21,603
| -54% | -$188K | ﹤0.01% | 1956 |
|
2022
Q3 | $473K | Buy |
39,771
+12,300
| +45% | +$146K | ﹤0.01% | 1424 |
|
2022
Q2 | $391K | Sell |
27,471
-6,585
| -19% | -$93.7K | ﹤0.01% | 1459 |
|
2022
Q1 | $709K | Buy |
34,056
+6,601
| +24% | +$137K | ﹤0.01% | 1317 |
|
2021
Q4 | $634K | Buy |
+27,455
| New | +$634K | ﹤0.01% | 1469 |
|
2020
Q4 | – | Sell |
-22,156
| Closed | -$787K | – | 2799 |
|
2020
Q3 | $787K | Buy |
+22,156
| New | +$787K | 0.01% | 1069 |
|